Sign In
Buy BSX
$47.69
+0.0100 (+0.0210%)
At Close: Jun 03, 2026
BSX Fairly Valued by DCF at $51
07:06am, Wednesday, 13'th May 2026
On May 13, 2026, we delve into a DCF analysis for Boston Scientific Corp (BSX), a company that has seen significant price fluctuations recently. The stock has e
Belo Sun to Commence Technical Studies on Volta Grande Gold Project
05:00pm, Tuesday, 12'th May 2026
TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or “Company”) (TSX: BSX, OTCQB: BSXGF) today announces the commencement of technical studies relating to its Volta G
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
04:30pm, Monday, 11'th May 2026
Boston Scientific Corporation is a leading medtech innovator facing recent share price underperformance due to market share erosion in electrophysiology and sector-wide sentiment shifts. Despite compe
BSX Q1 Neuromodulation Sales Rise 15% Y/Y: What Lies Behind the Growth?
12:26pm, Friday, 08'th May 2026
Boston Scientific's Neuromodulation unit posts 15% organic sales growth in Q1, fueled by pain management gains, the acquisition of Nalu and momentum in Intracept.
BSX Fairly Valued by DCF at $51
08:18am, Friday, 08'th May 2026
On May 08, 2026, we delve into the DCF analysis for Boston Scientific Corp (BSX), a company that has faced significant price performance challenges recently. Th
US FDA issues recall of Boston Scientific heart devices
05:04pm, Thursday, 07'th May 2026
Boston Scientific has issued an urgent recall to correct several heart devices after the U.S. Food and Drug Administration classified the action as its most serious recall, the regulator said on
Belo Sun Mining Corp. Begins Trading on OTCQX
12:48pm, Thursday, 07'th May 2026
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or the “Company”) (TSX: BSX; OTCQX: BSXGF) is pleased to announce that effective today, its common shares have qual
Penumbra, Inc. Reports First Quarter 2026 Financial Results
04:05pm, Wednesday, 06'th May 2026
ALAMEDA, Calif., May 6, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first quarter ended March 31, 2026.
SNN vs. BSX: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 05'th May 2026
Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew (SNN) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value oppo
NEW YORK--(BUSINESS WIRE)---- $BSX #BSX--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Boston Scientific Corporation (“Boston Scientific”
Polen Focus Growth Portfolio Q1 2026 Portfolio Update
11:32am, Monday, 04'th May 2026
In Q1 2026, Polen Focus Growth Portfolio returned -17.27% (net of fees) compared to -9.78% for the Index. Starbucks was the top performing absolute and relative contributor in Q1 amid positive signs t
New York, New York--(Newsfile Corp. - May 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between Ju
MARLBOROUGH, Mass., May 4, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 42nd Annual Strategic Decisions Conference on Wednesday, May 27, 2026.
3 Growth Stocks the Market Is Throwing Away and Why You Should Pick Them Up
06:56am, Monday, 04'th May 2026
Don't let their current weakness deter you. Sometimes, investors collectively misread and misprice the situation.
NEW YORK, May 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025
